Podcast Episodes

IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

Season 25 Episode 31

Dr Patrick Wen from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses the current and future management of IDH-mutant gliomas.  

CME information and select publications here.

Published on 2 months ago

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances

Season 25 Episode 30

Prof Meletios-Athanasios (Thanos) C Dimopoulos from the National and Kapodistrian University of Athens and Alexandra Hospital in Athens, Greece, and Dr Robert Z Orlowski from The University of Texas …

Published on 2 months, 1 week ago

Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances

Season 25 Episode 29

Professor Claire Harrison from the Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom, and Dr John Mascarenas from The Tisch Cancer Institute in New York, New York, provide their per…

Published on 2 months, 2 weeks ago

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances

Season 25 Episode 28

Dr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review r…

Published on 2 months, 3 weeks ago

Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit

Season 25 Episode 27

Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis.  

CME information and select publications here.

Published on 2 months, 3 weeks ago

Multiple Myeloma — Fourth Annual National General Medical Oncology Summit

Season 25 Episode 26

Clinical investigators discuss available data guiding the management of multiple myeloma.  

CME information and select publications here.

Published on 2 months, 4 weeks ago

Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Season 25 Episode 25

Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma. 

CME information and…

Published on 3 months ago

Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Season 25 Episode 24

Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia. 

CME information and select publicati…

Published on 3 months ago

Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies

Season 25 Episode 23

Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lym…

Published on 3 months ago

Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies

Season 25 Episode 22

Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and…

Published on 3 months, 1 week ago